Monogram Orthopaedics to Discuss Fiscal Year Results and 2024 Milestones in Upcoming Conference Call

Monogram Orthopaedics Inc., a leader in medical technology focusing on joint reconstruction and surgical robotics, is set to provide a comprehensive business update in a conference call scheduled for March 21, 2024, at 5:00 p.m. Eastern time. The call aims to discuss the company's performance for the fiscal year ending December 31, 2023, and to outline key regulatory updates, ongoing initiatives, and the technology strategy for the future.

Senior management including CEO Ben Sexson, CMO Doug Unis, MD, CTO Kamran Shamaei, and CFO Noel Knape will lead the discussion, which will be open for a question-and-answer period post-presentation. Stakeholders looking to participate can register via a provided link. A replay of the call will be made available on the company’s investor relations section shortly after the event.

Monogram Orthopaedics is pioneering in the field of orthopedic surgery, developing a system aimed at personalizing knee implants and enhancing surgical precision through robotics. The company is addressing a significant need within a $19.4 billion market, targeting improvements in the longevity and effectiveness of knee replacements. However, it's important to note that Monogram's robotic products are still pending FDA approval, with the timeline for clearance uncertain at this stage.